Addiction Vulnerability: Exploring Relationships Among Cigarette Smoking, Substance Misuse, and Early Psychosis

References

• Addy, P., Radhakrishnan, R., Cortes, J., & D'Souza, D. (2012). Comorbid alcohol, cannabis, and cocaine use disorders in schizophrenia: Epidemiology, consequences, mechanisms, and treatment. Focus, 10, 140–153. doi:10.1176/appi.focus.10.2.140
   Google Scholar
• Baker, A. L., Richmond, R., Kay-Lambkin, F. J., Filia, S. L., Castle, D., Williams, J. M., & Palazzi, K. (2017). Randomised controlled trial of a healthy lifestyle intervention among smokers with psychotic disorders: Outcomes to 36 months. Australian and New Zealand Journal of Psychiatry. Advance online publication. doi:10.1177/0004867417714336
   Web of Science ®Google Scholar
• Baker, A. L., Turner, A., Kelly, P. J., Spring, B., Callister, R., Collins, C. E., & Lewin, T. J. (2014). “Better health choices” by telephone: A feasibility trial of improving diet and physical activity in people diagnosed with psychotic disorders. Psychiatry Research, 220, 63–70. doi:10.1016/j.psychres.2014.06.035
   PubMed Web of Science ®Google Scholar
• Berk, M., Henry, L., Herrman, H., Jackson, J., & McGorry, P. (2010). The impact of smoking on clinical outcomes after first episode psychosis: Long-term outcome findings from the EPPIC 800 follow-up study. Journal of Dual Diagnosis, 6, 212–234. doi:10.1080/15504263.2010.537498
   Web of Science ®Google Scholar
• Cannon, T. D., Yu, C., Addington, J., Bearden, C. E., Cadenhead, K. S., Cornblatt, B. A., & Kattan, M. W. (2016). An individualized risk calculator for research in prodromal psychosis. American Journal of Psychiatry, 173, 980–988. doi:10.1176/appi.ajp.2016.15070890
   PubMed Web of Science ®Google Scholar
• Carney, R., Yung, A. R., Amminger, G. P., Bradshaw, T., Glozier, N., Hermens, D. F., & Purcell, R. (2017). Substance use in youth at risk for psychosis. Schizophrenia Research, 181, 23–39. doi:10.1016/j.schres.2016.08.026
   PubMed Web of Science ®Google Scholar
• Carpenter, W. T. (2016). Early detection of psychosis vulnerability: Progress, opportunity, and caution. American Journal of Psychiatry, 173, 949–950. doi:10.1176/appi.ajp.2016.16060746
   PubMed Web of Science ®Google Scholar
• Carr, V., Halpin, S., Lau, N., O'Brien, S., Beckman, J., & Lewin, T. (2000). A risk factor screening and assessment protocol for schizophrenia and related psychosis. Australian and New Zealand Journal of Psychiatry, 34, s170–s180. doi:10.1046/j.1440-1614.2000.00792.x
   PubMed Web of Science ®Google Scholar
• Chambers, A., Krystal, J. H., & Self, D. (2001). A neurobiological basis for substance abuse comorbidity in schizophrenia. Biological Psychiatry, 15, 71–83. doi:10.1016/S0006-3223(01)01134-9
   Google Scholar
• Clark, V., Baker, A., Lewin, T., Richmond, R., Kay-Lambkin, F., Filia, S., & Todd, J. (2017). Self-reported reasons for smoking: Predicting abstinence and implications for smoking cessation treatments among those with a psychotic disorder. Journal of Dual Diagnosis, 13, 6–14. doi:10.1080/15504263.2016.1271489
   PubMed Web of Science ®Google Scholar
• Compton, M. T., Kelley, M. E., Ramsay, C. E., Pringle, M., Goulding, S. M., Esterberg, M. L., & Walker, E. F. (2009). Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients. American Journal of Psychiatry, 166, 1251–1257. doi:10.1176/appi.ajp.2009.09030311
   PubMed Web of Science ®Google Scholar
• Conrad, A. M., Lewin, T. J., Sly, K. A., Schall, U., Halpin, S. A., Hunter, M., & Carr, V. J. (2014). Ten-year audit of clients presenting to a specialised service for young people experiencing or at increased risk for psychosis. BMC Psychiatry, 14, 318. doi:10.1186/s12888-014-0318-4
   PubMed Web of Science ®Google Scholar
• Conrad, A. M., Lewin, T. J., Sly, K. A., Schall, U., Halpin, S. A., Hunter, M., & Carr, V. J. (2017). Utility of risk-status for predicting psychosis and related outcomes: Evaluation of a 10-year cohort of presenters to a specialised early psychosis community mental health service. Psychiatry Research, 247, 336–344. doi:10.1016/j.psychres.2016.12.005
   PubMed Web of Science ®Google Scholar
• Darlington, R. B. (1968). Multiple regression in psychological research and practice. Psychological Bulletin, 69, 161–182. doi:10.1037/h0025471
   PubMed Web of Science ®Google Scholar
• De Leon, J., & Diaz, F. J. (2005). A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophrenia Research, 76, 135–157. doi:10.1016/j.schres.2005.02.010
   PubMed Web of Science ®Google Scholar
• Fusar-Poli, P., Borgwardt, S., Bechdolf, A., Addington, J., Riecher-Rossler, A., Schultze-Lutter, F., & Yung, A. (2013). The psychosis high-risk state: A comprehensive state-of-the-art review. Journal of American Medical Association Psychiatry, 70, 120–131. doi:10.1001/jamapsychiatry.2013.269
   Google Scholar
• Fusar-Poli, P., Nelson, B., Valmaggia, L., Yung, A. R., & McGuire, P. K. (2014). Comorbid depressive and anxiety disorders in 509 individuals with an at-risk mental state: Impact on psychopathology and transition to psychosis. Schizophrenia Bulletin, 40, 120–131. doi:10.1093/schbul/sbs136
   PubMed Web of Science ®Google Scholar
• Galletly, C., Castle, D., Dark, F., Humberstone, V., Jablensky, A., Killackey, E., & Tran, N. (2016). Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Australian and New Zealand Journal of Psychiatry, 50, 410–472. doi:10.1177/0004867416641195
   PubMed Web of Science ®Google Scholar
• George, T. (2007). Neurobiological links between nicotine addiction and schizophrenia. Journal of Dual Diagnosis, 3, 27–42. doi:10.1300/J374v03n03_04
   Google Scholar
• Gurillo, P., Jauhar, S., Murray, R. M., & MacCabe, J. H. (2015). Does tobacco use cause psychosis? Systematic review and meta-analysis. The Lancet Psychiatry, 2, 718–725. doi:10.1016/S2215-0366(15)00152-2
   PubMed Web of Science ®Google Scholar
• Heishman, S. J., Kleykamp, B. A., & Singleton, E. G. (2010). Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology, 210, 453–469. doi:10.1007/s00213-010-1848-1
   PubMed Web of Science ®Google Scholar
• Kirkbride, J. B., Errazuriz, A., Croudace, T. J., Morgan, C., Jackson, D., Boydell, J., & Jones, P. B. (2012). Incidence of schizophrenia and other psychoses in England, 1950–2009: A systematic review and meta-analyses. PLoS ONE, 7, 1–21. doi:10.1371/journal.pone.0031660
   Web of Science ®Google Scholar
• Kristensen, K., & Cadenhead, K. S. (2007). Cannabis abuse and risk for psychosis in a prodromal sample. Psychiatry Research, 151, 151–154. doi:10.1016/j.psychres.2006.10.001
   PubMed Web of Science ®Google Scholar
• Krystal, J. H., D'Souza, D. C., Madonick, S., & Petrakis, I. L. (1999). Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients. Schizophrenia Research, 35, S35–S49. doi:10.1016/S0920-9964(98)00162-5
   PubMed Web of Science ®Google Scholar
• Lawrence, D., Mitrou, F., & Zubrick, R. (2009). Smoking and mental illness: Results from population surveys in Australia and the United States. BMC Public Health, 9, 285–299. doi:10.1186/1471-2458-9-285
   PubMed Web of Science ®Google Scholar
• Leonard, S., Adler, L. E., Benhammou, K., Berger, R., Breese, C. R., Drebing, C., & Freedman, R. (2001). Smoking and mental illness. Pharmacology Biochemistry and Behavior, 70, 561–570. doi:10.1016/S0091-3057(01)00677-3
   PubMed Web of Science ®Google Scholar
• Lerman, C., Caporaso, N., Audrain, J., Main, D., Bowman, E., Lockshin, B., & Shields, P. (1999). Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychology, 18, 14–20. doi:10.1037/0278-6133.18.1.14
   PubMed Web of Science ®Google Scholar
• Ma, X., Li, C., Meng, H., Du, L., Wang, Q., Wang, Y., & Li, T. (2010). Premorbid tobacco smoking is associated with later age at onset in schizophrenia. Psychiatry Research, 178, 461–466. doi:10.1016/j.psychres.2009.08.014
   PubMed Web of Science ®Google Scholar
• Moore, E., Mancuso, S. G., Slade, T., Galletly, C., & Castle, D. J. (2012). The impact of alcohol and illicit drugs on people with psychosis: The second Australian national survey of psychosis. Australian and New Zealand Journal of Psychiatry, 46, 864–878. doi:10.1177/0004867412443900
   PubMed Web of Science ®Google Scholar
• Morgan, V. A., Waterreus, A., Jablensky, A., Mackinnon, A., McGrath, J. J., Carr, V., & Saw, S. (2012). People living with psychotic illness in 2010: The second Australian national survey of psychosis. Australian and New Zealand Journal of Psychiatry, 46, 735–752. doi:10.1177/0004867412449877
   PubMed Web of Science ®Google Scholar
• Myles, N., Newall, H., Curtis, J., Nilssen, O., Shiers, D., & Large, M. (2012). Tobacco use before, at, and after first episode psychosis: A systematic meta-analysis. Journal of Clinical Psychiatry, 73, 468–475. doi:10.4088/JCP.11r07222
   PubMed Web of Science ®Google Scholar
• NSW Department of Health. (2009). New South Wales School Students Health Behaviours Survey: 2008 report. Sydney, Australia: New South Wales Department of Health.
   Google Scholar
• Schultze-Lutter, F., Michel, C., Schmidt, S. J., Schimmelmann, B. G., Maric, N. P., Salokangas, R. K. R., & Klosterkötter, J. (2015). EPA guidance on the early detection of clinical high risk states of psychoses. European Psychiatry, 30, 405–416. doi:10.1016/j.eurpsy.2015.01.010
   PubMed Web of Science ®Google Scholar
• Shiffman, S. (1993). Assessing smoking patterns and motives. Journal of Consulting & Clinical Psychology, 61, 732–742. doi:10.1037/0022-006X.61.5.732
   PubMed Web of Science ®Google Scholar
• Smith, G. N., Wong, H., MacEwan, G. W., Kopala, L. C., Ehmann, T. S., Thornton, A. E., & Honer, W. G. (2009). Predictors of starting to smoke cigarettes in patients with first episode psychosis. Schizophrenia Research, 108, 258–264. doi:10.1016/j.schres.2008.12.013
   PubMed Web of Science ®Google Scholar
• Steel, Z., Marnane, C., Iranpour, C., Chey, T., Jackson, J. W., Patel, V., & Silove, D. (2014). The global prevalence of common mental disorders: A systematic review and meta-analysis 1980–2013. International Journal of Epidemiology, 43, 476–493. doi:10.1093/ije/dyu038
   PubMed Web of Science ®Google Scholar
• Swarbrick, M. A., Cook, J. A., Razzano, L. A., Jonikas, J. A., Gao, N., Williams, J., & Yudof, J. (2017). Correlates of current smoking among adults served by the public mental health system. Journal of Dual Diagnosis, 13, 82–90. doi:10.1080/15504263.2017.1296603
   PubMed Web of Science ®Google Scholar
• Thornton, L. K., Baker, A. L., Lewin, T. J., Kay-Lambkin, F. J., Kavanagh, D., Richmond, R., & Johnson, M. P. (2012). Reasons for substance use among people with mental disorders. Addictive Behaviors, 37, 427–434. doi:10.1016/j.addbeh.2011.11.039
   PubMed Web of Science ®Google Scholar
• Wade, D., Harrigan, S., Edwards, J., Burgess, P. M., Whelan, G., & McGorry, P. D. (2006). Patterns and predictors of substance use disorders and daily tobacco use in first-episode psychosis. Australian and New Zealand Journal of Psychiatry, 39, 892–898. doi:10.1080/j.1440-1614.2005.01699.x
   Web of Science ®Google Scholar
• Weiser, M., Reichenberg, A., Grotto, I., Yasvitzky, R., Rabinowitz, J., Lubin, G., & Davidson, M. (2004). Higher rates of cigarette smoking in male adolescents before the onset of schizophrenia: A historical-prospective cohort study. American Journal of Psychiatry, 161, 1219–1223. doi:10.1176/appi.ajp.161.7.1219
   PubMed Web of Science ®Google Scholar
• Wesnes, K., & Warburton, D. M. (1983). Smoking, nicotine and human performance. Pharmacology & Therapeutics, 21, 189–208. doi:10.1016/0163-7258(83)90072-4
   PubMed Web of Science ®Google Scholar
• Wigman, J. T. W., van Nierop, M., Vollebergh, W. A. M., Lieb, R., Beesdo-Baum, K., Wittchen, H.-U., & van Os, J. (2012). Evidence that psychotic symptoms are prevalent in disorders of anxiety and depression, impacting on illness onset, risk, and severity—implications for diagnosis and ultra-high risk research. Schizophrenia Bulletin, 38, 247–257. doi:10.1093/schbul/sbr196
   PubMed Web of Science ®Google Scholar
• Yung, A., & McGorry, P. (1996). The prodromal phase of first-episode psychosis: Past and current conceptualizations. Schizophrenia Bulletin, 22, 353–370. doi:10.1093/schbul/22.2.353
   PubMed Web of Science ®Google Scholar
• Yung, A. R., Phillips, L. J., Yuen, H. P., Francey, S. M., McFarlane, C. A., Hallgren, M., & McGorry, P. D. (2003). Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) group. Schizophrenia Research, 60, 21–32. doi:10.1016/S0920-9964(02)00167-6
   PubMed Web of Science ®Google Scholar
• Yung, A. R., Yuen, H. P., McGorry, P. D., Phillips, L. J., Kelly, D., Dell'Olio, M., & Buckby, J. (2005). Mapping the onset of psychosis: The Comprehensive Assessment of At-Risk Mental States. Australian and New Zealand Journal of Psychiatry, 39, 964–971. doi:10.1080/j.1440-1614.2005.01714.x
   PubMed Web of Science ®Google Scholar
• Zammit, S., Allebeck, P., Dalman, C., Lundberg, I., Hemmingsson, T., & Lewis, G. (2003). Investigating the association between cigarette smoking and schizophrenia in a cohort study. American Journal of Psychiatry, 160, 2216–2221. doi:10.1176/appi.ajp.160.12.2216
   PubMed Web of Science ®Google Scholar
• Zammit, S., Spurlock, G., Williams, H., Norton, N., Williams, N., O'Donovan, M. C., & Owen, M. J. (2007). Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: Interactions with tobacco and cannabis use. The British Journal of Psychiatry, 191, 402–407. doi:10.1192/bjp.bp.107.036129
   PubMed Web of Science ®Google Scholar